Skip to main content
Top
Published in: BMC Infectious Diseases 1/2021

Open Access 01-12-2021 | Itraconazole | Case report

Eumycetoma Osteomyelitis Calcaneus in Adolescent; report of case and literature review

Authors: Ammar Awad, Adnan Alnaser, Hozifa Abd-elmaged, Reyad Abdallah, Hussam S. Khougali

Published in: BMC Infectious Diseases | Issue 1/2021

Login to get access

Abstract

Background

Mycetoma is the most common neglected disease in humans. It is a chronic, progressive, and destructive disease primarily caused by fungi or bacteria characterized by formation of dark pale grains commonly involve skin, soft tissue and rarely bone.

Case presentation

A 19 year old male patient with chronic right ankle pain, swelling and abscess formation for more than 1 year, patient was treated repeatedly with incision and drainage without any success. No X-ray, biopsy or swab for culture and sensitivity had been considered through the course of presentation. Patient was referred to Omdurman hospital where osteomyelitis secondary euomycetoma infection has been confirmed based on radiological and pathological assessment. Patient was treated surgically with aggressive debridement and bone curettage plus postoperative Itraconazole for 1 year.

Conclusion

Clinicians must consider osteomyelitis as important differential diagnosis during initial assessment Eumycetoma infection in adults. Aggressive bone curettage followed by regular X-ray follow up can be limb saving procedure in such cases.
Literature
1.
go back to reference Zijlstra EE, Van De Sande WW, Fahal AH. Mycetoma: a long journey from neglect. PLoS Negl Trop Dis. 2016;10(1):e0004244.CrossRef Zijlstra EE, Van De Sande WW, Fahal AH. Mycetoma: a long journey from neglect. PLoS Negl Trop Dis. 2016;10(1):e0004244.CrossRef
2.
go back to reference Develoux M, Dieng MT, Kane A, Ndiaye B. Management of mycetoma in West-Africa. Bull Soc Pathol Exot. 2004;96(5):376–82. Develoux M, Dieng MT, Kane A, Ndiaye B. Management of mycetoma in West-Africa. Bull Soc Pathol Exot. 2004;96(5):376–82.
3.
go back to reference Fahal AH. Mycetoma thorn on the flesh. Trans R Soc Trop Med Hyg. 2004;98(1):3–11.CrossRef Fahal AH. Mycetoma thorn on the flesh. Trans R Soc Trop Med Hyg. 2004;98(1):3–11.CrossRef
5.
go back to reference Bonifaz A, Tirado-Sánchez A, Calderón L, Saúl A, Araiza J, et al. Mycetoma: experience of 482 cases in a single center in Mexico. PLoS Negl Trop Dis. 2014;8(8):e3102.CrossRef Bonifaz A, Tirado-Sánchez A, Calderón L, Saúl A, Araiza J, et al. Mycetoma: experience of 482 cases in a single center in Mexico. PLoS Negl Trop Dis. 2014;8(8):e3102.CrossRef
8.
go back to reference Welsh O, Al-Abdely HM, Salinas-Carmona MC, Fahal AH. Mycetoma medical therapy. PLoS Negl Trop Dis. 2014;8(10):e3218.CrossRef Welsh O, Al-Abdely HM, Salinas-Carmona MC, Fahal AH. Mycetoma medical therapy. PLoS Negl Trop Dis. 2014;8(10):e3218.CrossRef
Metadata
Title
Eumycetoma Osteomyelitis Calcaneus in Adolescent; report of case and literature review
Authors
Ammar Awad
Adnan Alnaser
Hozifa Abd-elmaged
Reyad Abdallah
Hussam S. Khougali
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2021
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-021-06695-3

Other articles of this Issue 1/2021

BMC Infectious Diseases 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.